Clinical Trials Browser

Interventional × Breast Neoplasms × efineptakin alfa × Clear all

NCT03752723 2024-03-05

KEYNOTE-899

Phase 1/2 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04054752 2023-11-02

Vaccine Response With NT-I7

Phase 1 Withdrawn

BreastGastrointestinalGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Colorectal Neoplasms